1 An interim analysis in 2020 led to the trial being unblinded and preliminary results of a highly significant improvement in DFS being presented at ASCO 2020. 1 The study follow-up was still ongoing, awaiting overall survival (OS) outcomes.
← all excerpts
Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities.
1
—
—